Not Yet RecruitingNot Applicable

Biomarker-s of Abusive Head Trauma by Proteomics

France, Switzerland174 participantsStarted 2023-02

Plain-language summary

The aim of our study is to highlight biomarker-s of Abusive Head Trauma by proteomics analyses on the serum of child victims of abuse.

Who can participate

Age range2 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age : 0-2 y.o * Medical consultation for malaise, seizure (without fever), loss of consciousness, traumatic bain injury, or cranioplasty * Blood test during medical care * Accepted informed consent Exclusion Criteria: * Refused informed consent * For control groups : medical history of child abuse * For AHT group : rare metabolic disease (Menkes, etc..)

What they're measuring

Highlight novel biomarker-s of AHT

Timeframe: Hospital admission to discharge (up to 3 days)

Trial details

NCT IDNCT05626465

SponsorUniversity Hospital, Geneva

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-02

Contact for this trial

Kim Wiskott, MD

0041797737424 kim.wiskott@hcuge.ch

View on ClinicalTrials.gov More Abuse, Child trials